APPH.DE
Price:
$11
Market Cap:
$91.63M
Apontis Pharma AG markets and sells medical drugs for indication fields of internal medicine in Germany. It develops, promotes, and sells a portfolio of single pills and other pharmaceutical products with a focus on cardiovascular diseases, such as hypertension, hyperlipidemia, and secondary prevention, as well as respiratory diseases and diabetes. The company was founded in 1946 is headquartered in Monheim am Rhein, Germany.
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2021-05-11
Stock Exchange
XETRA
Ticker
APPH.DE
According to Apontis Pharma AG’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Apontis Pharma AG over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), APPH.DE's Dividend Yield was at its highest in in the December 2020 quarter at 0%. The Dividend Yield was at its lowest in in the December 2020 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Apontis Pharma AG Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
The current Dividend Yield of Apontis Pharma AG (APPH.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Apontis Pharma AG’s Dividend Yield is less than MPH Health Care AG (5.04%), less than H100 Group AB N (0%), less than LIMES Schlosskliniken AG (0%), less than FamiCord AG (0%), less than DocCheck AG (6.82%), less than SynBiotic SE (0%), less than BRAIN Biotech AG (0%), less than Heidelberg Pharma AG (0%), less than MeVis Medical Solutions AG (3.77%), less than 4basebio PLC (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 5.04% | $101.90M | |
| 0% | $53.30M | |
| 0% | $103.20M | |
| 0% | $104.59M | |
| 6.82% | $55.81M | |
| 0% | $16.94M | |
| 0% | $57.46M | |
| 0% | $113.22M | |
| 3.77% | $45.86M | |
| 0% | $108.39M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Apontis Pharma AG using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Apontis Pharma AG or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Apontis Pharma AG's Dividend Yield?
How is the Dividend Yield calculated for Apontis Pharma AG (APPH.DE)?
What is the highest Dividend Yield for Apontis Pharma AG (APPH.DE)?
What is the 3-year average Dividend Yield for Apontis Pharma AG (APPH.DE)?
What is the 5-year average Dividend Yield for Apontis Pharma AG (APPH.DE)?
How does the current Dividend Yield for Apontis Pharma AG (APPH.DE) compare to its historical average?